Jayakar, V. (2014). Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia. Medknow Publications & Media Pvt Ltd.
استشهاد بنمط شيكاغوJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
MLA استشهادJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.